SIPHA Company Description

Société des Industries Pharmaceutiques de Tunisie - S.A. engages in the research, development, manufacture, packaging, and marketing of pharmaceutical products for human use in Tunisia and internationally.

It provides rheumatology drugs, such as MYORELAX, NIFLUMIC, and ALGESAL SURACTIVE; stomatology drugs, including HEXABAIN; and ANALGAN CODEINE 300mg/25mg indicated for the symptomatic treatment of moderate and intense pain.

The company was founded in 1989 and is headquartered in Ben Arous, Tunisia.

Société des Industries Pharmaceutiques de Tunisie - S.A.

Country	Tunisia
Founded	1989
Industry	Pharmaceutical Preparations
Employees	744
CEO	Anis Klouz

Contact Details

Address: Fondouk Choucha Ben Arous, 2013 Tunisia
Phone	216 71 381 222
Website	siphat.rns.tn

Stock Details

Ticker Symbol	SIPHA
Exchange	Tunis Stock Exchange
Fiscal Year	January - December
Reporting Currency	TND
SIC Code	2834

Key Executives

Name	Position
Anis Klouz	Chief Executive Officer